Ap. Theon et al., MEGAVOLTAGE IRRADIATION OF NEOPLASMS OF THE NASAL AND PARANASAL CAVITIES IN 77 DOGS, Journal of the American Veterinary Medical Association, 202(9), 1993, pp. 1469-1475
Seventy-seven dogs with malignant tumors of the nasal and paranasal ca
vities were treated by use of radiotherapy. The tumors included carcin
omas (58) and sarcomas (19). Radiographic findings, including site of
involvement and tumor extension, were the basis of clinical staging. S
taging was performed according to the tumor, node, metastasis staging
of the World Health Organization, and a modified staging scheme based
on prognostic factors that seemed to correlate best with response to t
reatment. All irradiations were done with a telecobalt 60 unit. Fifty-
six dogs were treated with irradiation alone, and 21 had partial tumor
resection prior to radiotherapy. Treatment dose was 48 Gy (minimal tu
mor dose) administered on a Monday-Wednesday-Friday basis at 4 Gy/frac
tion over 4 weeks. The irradiation technique emphasized rostral field
with a generous treatment volume. Duration of follow-up after irradiat
ion ranged from 1 month to 61 months. The 1- and 2-year overall surviv
al rates were 60.3% and 25%, respectively, and the 1- and 2-year relap
se-free survival rates were 38.2% and 17.6%, respectively. Results of
histologic examination and our modified staging scheme were significan
t (P = 0.02 and P = 0.04, respectively) prognostic factors of relapse-
free survival. Conversely, tumor site, tumor extension, World Health O
rganization clinical stage, and cytoreductive surgery prior to irradia
tion did not affect the outcome of treatment. According to our modifie
d staging scheme, dogs with stage-2 disease have a poorer prognosis th
an dogs with stage-1 disease, with a relative risk of relapse 2.3-fold
higher. Dogs with carcinoma had a poorer prognosis than dogs with sar
coma (predominantly chondrosarcoma) with a relative risk of relapse 3.
3-fold higher. Furthermore, dogs with chondrosarcomas fared significan
tly (P = 0.05) better than those with adenocarcinomas. Most acute radi
ation reactions were acceptable. Chronic ocular complications were see
n in 45% (35/77) of the dogs.